Global Cord Blood
(OTC) CORBF
Global Cord Blood Financials at a Glance
Market Cap
$127.29M
Revenue (TTM)
$1.23B
Net Income (TTM)
$471.44M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.95
Volume
10
Open
$0.95
Price
$0.95
Volume
10
Open
$0.95
Previous Close
$0.95
Daily Range
$0.95 - $0.95
52-Week Range
$0.20 - $1.75
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.95
Volume
10
Open
$0.95
Previous Close
$0.95
Daily Range
$0.95 - $0.95
52-Week Range
$0.20 - $1.75
CORBF News
Golf Clap for China Cord Blood
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Global Cord Blood
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1,202
CEO
Ting Zheng, EMBA
Website
www.globalcordbloodcorp.comHeadquarters
Central, HK
CORBF Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
49%
Net Income Margin
40%
Return on Equity
0%
Return on Capital
8%
Return on Assets
6%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$127.29M
Shares Outstanding
133.91M
Volume
10
Avg. Volume
1.15K
Financials (TTM)
Gross Profit
$1.06B
Operating Income
$608.87M
EBITDA
$656.79M
Operating Cash Flow
$613.61M
Capital Expenditure
$19.79M
Free Cash Flow
$593.82M
Cash & ST Invst.
$6.66B
Total Debt
$147.00K
Global Cord Blood Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$297.21M
-5.7%
Gross Profit
$255.23M
-4.5%
Gross Margin
85.88%
N/A
Market Cap
$127.29M
N/A
Market Cap/Employee
$105.90K
N/A
Employees
1,202
N/A
Net Income
$106.80M
-21.7%
EBITDA
$142.18M
-16.2%
Quarterly Fundamentals
Net Cash
$1.05B
-83.1%
Accounts Receivable
$25.45M
-81.2%
Inventory
$7.24M
-80.4%
Long Term Debt
$23.00K
-76.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
5.87%
N/A
Return on Invested Capital
7.72%
N/A
Free Cash Flow
$327.00K
+40.3%
Operating Cash Flow
$327.00K
+40.3%